Cardiac Research

Research is one of the components that make us unique at the Baptist Heart & Vascular Institute.  Our highly trained staff is dedicated to providing the latest innovations and newest therapies in a community-based setting.  Baptist Health Lexington is working to improve the lives of our patients with heart and vascular disease.

Below is a listing of current cardiac clinical trials:

IRB 884 CYPRESS Study:
A Prospective, Randomized, Multi-Center, Double-Blind Trial to Assess the Effectiveness and Safety of Different Durations of Dual Anti-Platelet Therapy (non-DAPT) in Subjects Undergoing Percutaneous Coronary Intervention with the Cypher® Sirolimus-Eluting Coronary Stent (CYPHER® STENT)

Purpose: Long term registry to collect data on the Cordis CYPHER® STENT.

Eligibility: Any patient with an indication for PCI (elective or urgent).  

For additional information, please contact Jeannie Hamilton Chapman at 859-260-6172.

IRB 909 TRANSLATE-ACS Study: 
The TRANSLATE-ACS Study: Treatment with ADP Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events after Acute Coronary Syndrome

Purpose:  This is an observational study to evaluate the real world effectiveness and use of prasugrel and other ADP receptor inhibitor therapies among myocardial infarction (MI) patients treated with percutaneous coronary intervention (PCI) during the index hospitalization. Patient management and treatment decisions are at the discretion of the care team per routine clinical practice.

Eligibility:  Patients admitted for NSTEMI or STEMI undergoing PCI and treated with an ADP receptor inhibitor during the index hospitalization.

For additional information, please contact Jeannie Hamilton Chapman at 859-260-6172.